Showing results (161-170 of 271) with videos related to

Sort By:
Pageof 28
Blood Advances|December 22, 2018
Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomasErin G Reid, David Looney, Frank Maldarelli, et al.
Cancer Reports (Hoboken, N.J.)|June 1, 2026
Case Report: Synchronous Manifestations of Kaposi Sarcoma Herpesvirus-Associated DisordersKandice Roberts, Paula Valiño Ramos, Saurabh Jindal, et al.
The Journal of Clinical Investigation|December 9, 2014
LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesisShi-Dong Ma, Xuequn Xu, Julie Plowshay, et al.
Haematologica|February 29, 2020
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphomaJoseph A Sparano, Jeannette Y Lee, Lawrence D Kaplan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphomaJia Ruan, Peter Martin, Richard R Furman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphomaJohn P Leonard, Morton Coleman, Lale Kostakoglu, et al.
JCO Global Oncology|July 8, 2020
Challenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 StudyRobert M Strother, Satish Gopal, Meg Wirth, et al.
Pageof 28